核心概念
A Georgia man was sentenced to 27 years in prison for orchestrating a $463 million genetic testing scheme to defraud Medicare.
摘要
The content discusses the sentencing of Minal Patel, the owner of LabSolutions LLC, for his involvement in a Medicare fraud scheme. Patel conspired with various entities to target Medicare beneficiaries with false claims about expensive cancer genetic tests. The scheme involved kickbacks, bribes, and fraudulent contracts to obtain doctors' orders for unnecessary tests. Patel was convicted of multiple charges, including health care fraud and money laundering. The scheme resulted in over $187 million in payments from Medicare, with Patel personally receiving over $21 million. The crackdown on genetic testing fraud led to multiple arrests and charges in several states.
- Minal Patel sentenced to 27 years for Medicare fraud scheme
- Scheme involved false claims about expensive genetic tests
- Patel convicted of health care fraud, money laundering, and kickbacks
- Over $187 million paid by Medicare, with Patel receiving $21 million personally
- Crackdown on genetic testing fraud resulted in multiple arrests
统计
From July 2016 through August 2019, LabSolutions submitted more than $463 million in claims to Medicare, with over $187 million paid by Medicare.
Patel personally received over $21 million in Medicare proceeds during the scheme.
引用
"Patel conspired with patient brokers, telemedicine companies, and call centers to target Medicare beneficiaries with telemarketing calls falsely stating that Medicare covered expensive cancer genetic tests."
"To conceal the kickbacks and bribes, Patel required patient brokers to sign sham contracts."